Literature DB >> 12567295

What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia?

Thomas M File, Lionel A Mandell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12567295     DOI： 10.1086/367545

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  15 in total

1.  Addition of a macrolide to a ss-lactam in bacteremic pneumococcal pneumonia.

Authors:  R Dwyer; A Ortqvist; E Aufwerber; B Henriques Normark; T J Marrie; M A Mufson; A Torres; M A Woodhead; M Alenius; M Kalin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-08       Impact factor: 3.267

Review 2.  Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis.

Authors:  H Tang; T Huang; J Jing; H Shen; W Cui
Journal:  Infection       Date:  2009-10-13       Impact factor: 3.553

3.  Lack of effect of combination antibiotic therapy on mortality in patients with pneumococcal sepsis.

Authors:  S Harbarth; J Garbino; J Pugin; J A Romand; D Pittet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-10       Impact factor: 3.267

Review 4.  [Procalcitonin-based algorithm. Management of antibiotic therapy in critically ill patients].

Authors:  M Hochreiter; S Schroeder
Journal:  Anaesthesist       Date:  2011-07       Impact factor: 1.041

5.  Community-acquired pneumonia of mixed etiology: prevalence, clinical characteristics, and outcome.

Authors:  F Gutiérrez; M Masiá; J C Rodríguez; C Mirete; B Soldán; S Padilla; I Hernández; G Royo; A Martin-Hidalgo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-06       Impact factor: 3.267

6.  Procalcitonin and pneumonia: is it a useful marker?

Authors:  Mirjam Christ-Crain; Beat Müller
Journal:  Curr Infect Dis Rep       Date:  2007-05       Impact factor: 3.725

Review 7.  Adherence to guidelines for community-acquired pneumonia: does it decrease cost of care?

Authors:  Patricia D Brown
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

8.  Improving therapeutic strategies for secondary bacterial pneumonia following influenza.

Authors:  Jonathan A McCullers; B Keith English
Journal:  Future Microbiol       Date:  2008-08       Impact factor: 3.165

Review 9.  [Diagnostic markers and assessment of efficacy of antibacterial therapy].

Authors:  K-F Bodmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-04-05       Impact factor: 0.840

10.  Third Case of Streptococcus suis Infection in Greece.

Authors:  Marianneta Chatzopoulou; Ioanna Voulgaridou; Dimitrios Papalas; Petros Vasiliou; Maria Tsiakalou
Journal:  Case Rep Infect Dis       Date:  2015-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.